Cardiovascular Journal of Africa: Vol 27 No 1 (January/February 2016)

12 / 64

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 1, January/February 2016 10 AFRICA
16. Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in
long-QT syndrome genes : KVLQT1, HERG, SCN5A, KCNE1, and
KCNE2. Circulation 2000; 102(10): 1178–1185.
17. Larsen LA, Andersen PS, Kanters J, et al. Screening for mutations and
polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac
HERG/MiRP1 ion channel: implications for acquired and congenital
long Q-T syndrome. Clin Chem 2001; 47 (8): 1390–1395.
18. Mazhari R, Greenstein JL, Winslow RL, Marbán E, Nuss HB.
Molecular interactions between two long-QT syndrome gene products,
HERG and KCNE2, rationalized by in vitro and in silico analysis. Circ
Res 2001; 89(1): 33–38.
19. Zhang M, Wang Y, Jiang M, et al. KCNE2 protein is more abundant
in ventricles than in atria and can accelerate hERG protein degradation
in a phosphorylation-dependent manner. Am J Physiol – Heart Circ
Physiol 2012; 302(4): H910–922.
20. Tinel N. KCNE2 confers background current characteristics to the
cardiac KCNQ1 potassium channel. Eur Mole Biol Org J 2000; 19(23):
6326–6330.
21. Towbin JA, Vatta M. Molecular biology and the prolonged QT
syndromes. Am J Med 2001; 110(5): 385–398.
22. Chun KRJ, Koenen M, Katus HA, Zehelein J. Expression of the IKr
components KCNH2 (rERG) and KCNE2 (rMiRP1) during late rat
heart development. Exp Mol Med 2004; 36(4): 367–371.
23. Kawakami K, Nagatomo T, Abe H, et al. Comparison of HERG
channel blocking effects of various β-blockers – implication for clinical
strategy. Br J Pharmacol 2006; 147(6): 642–652.
24. Clark RE, Christlieb I, Sanmarco M, Diaz-Perez R, Dammann JF,
Zipser ME. Relationship of hypoxia to arrhythmia and cardiac conduc-
tion hemorrhage: an experimental study. Circulation 1963; 27(4):
742–747.
25. Ju YK, Saint DA, Gage PW. Hypoxia increases persistent sodium
current in rat ventricular myocytes. J Physiol 1996; 497(Pt 2): 337–347.
26. Prandota J. Possible pathomechanisms of sudden infant death syndrome:
key role of chronic hypoxia, infection/inflammation states, cytokine
irregularities, and metabolic trauma in genetically predisposed infants.
Am J Ther 2004; 11(6): 517–546.
27. Neary MT, Mohun TJ, Breckenridge RA. A mouse model to study
the link between hypoxia, long QT interval and sudden infant death
syndrome. Dis Model Mech 2013; 6(2): 503–507.
28. Conforti L, Millhorn DE. Selective inhibition of a slow-inactivating
voltage-dependent K+ channel in rat PC12 cells by hypoxia. J Physiol
1997; 502(Pt 2): 293–305.
29. Wang J, Weigand L, Wang W, Sylvester JT, Shimoda LA. Chronic
hypoxia inhibits Kv channel gene expression in rat distal pulmonary
artery. Am J Physiol Lung Cell Mol Physiol 2005; 288(6): L1049–1058.
30. Nanduri J, Bergson P, Wang N, Ficker E, Prabhakar NR. Hypoxia
inhibits maturation and trafficking of HERG K+ channel protein:
Role of Hsp90 and ROS. Biochem Biophys Res Commun 2009; 388(2):
212–216.
31. Xia S, Wang Y, Zhang Y, et al. Dynamic changes in HCN2, HCN4,
KCNE1, and KCNE2 expression in ventricular cells from acute myocar-
dial infarction rat hearts. Biochem Biophys Res Commun 2010; 395(3):
330–335.
32. Van der Ven PF, Obermann WM, Lemke B, Gautel M, Weber K, Fürst
DO. Characterization of muscle filamin isoforms suggests a possible role
of gamma-filamin/ABP-L in sarcomeric Z-disc formation. Cell Motil
Cytoskeleton 2000; 45(2): 149–162.
33. Cho K-O, Lee K-E, Youn D-Y, et al. Decreased vulnerability of
hippocampal neurons after neonatal hypoxia-ischemia in bis-deficient
mice. Glia 2012; 60(12): 1915–1929.
34. Nissou M-F, El Atifi M, Guttin A, et al. Hypoxia-induced expression of
VE-cadherin and filamin B in glioma cell cultures and pseudopalisade
structures. J Neurooncol 2013; 113(2): 239–249.
35. Kley RA, Hellenbroich Y, van der Ven PFM, et al. Clinical and morpho-
logical phenotype of the filamin myopathy: a study of 31 German
patients. Brain 2007; 130(12): 3250–3264.
36. Goldfarb LG, Olivé M, Vicart P, Goebel HH. Intermediate filament
diseases: desminopathy. Adv Exp Med Biol 2008; 642: 131–164.
37. Feng Y, Walsh CA. The many faces of filamin: a versatile molecular
scaffold for cell motility and signalling. Nat Cell Biol 2004; 6(11):
1034–1038.
38. Ithychanda SS, Hsu D, Li H, et al. Identification and characterization
of multiple similar ligand-binding repeats in filamin implication on
filamin-mediated receptor clustering and cross-talk. J Biol Chem 2009;
284(50): 35113–35121.
39. Lecour S, Suleman N, Deuchar GA, et al. Pharmacological precondi-
tioning with tumor necrosis factor-α activates signal transducer and
activator of transcription-3 at reperfusion without involving classic
prosurvival kinases (Akt and extracellular signal-regulated kinase).
Circulation 2005; 112(25): 3911–3918.
40. Bradford MM. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding. Anal Biochem 1976; 72: 248–254.
41. Abbott GW. Disease-associated mutations in KCNE potassium channel
subunits (MiRPs) reveal promiscuous disruption of multiple currents
and conservation of mechanism. Fed Am Soc Exp Biol J 2002; 16(3):
390–400.
42. Fujita M, Mitsuhashi H, Isogai S, et al. Filamin C plays an essential role
in the maintenance of the structural integrity of cardiac and skeletal
muscles, revealed by the medaka mutant zacro. Dev Biol 2012; 361(1):
79–89.
43. Nakagawa K, Sugahara M, Yamasaki T, et al. Filamin associates with
stress signalling kinases MKK7 and MKK4 and regulates JNK activa-
tion. Biochem J 2010; 427(2): 237–245.
44. Razinia Z, Mäkelä T, Ylänne J, Calderwood DA. Filamins in mechano-
sensing and signaling. A Rev Biophys 2012; 41(1): 227–246.
45. Boraldi F, Annovi G, Carraro F, et al . Hypoxia influences the cellular
cross-talk of human dermal fibroblasts. A proteomic approach. Biochim
Biophys Acta BBA – Proteins Proteomics 2007; 1774(11): 1402–1413.
46. Hastie LE, Patton WF, Hechtman HB, Shepro D. H2 O2 -induced
filamin redistribution in endothelial cells is modulated by the cyclic
AMP-dependent protein kinase pathway. J Cell Physiol 1997; 172(3):
373–381.
47. Kesner BA, Ding F, Temple BR, Dokholyan NV. N-terminal strands
of filamin Ig domains act as a conformational switch under biological
forces. Proteins 2010; 78(1): 12–24.
48. Petrecca K, Miller DM, Shrier A. Localization and enhanced current
density of the Kv4.2 potassium channel by interaction with the actin-
binding protein filamin. J Neurosci Off J Soc Neurosci 2000; 20(23):
8736–8744.
49. Sampson LJ, Leyland ML, Dart C. Direct interaction between the
actin-binding protein filamin-A and the inwardly rectifying potassium
channel, Kir2.1. J Biol Chem 2003; 278(43): 41988–41997.
50. Kim EY, Ridgway LD, Dryer SE. Interactions with filamin A stimulate
surface expression of large-conductance Ca 2+-activated K+ channels
in the absence of direct actin binding. Mol Pharmacol 2007; 72(3):
622–630.
51. An WF, Bowlby MR, Betty M, et al . Modulation of A-type potas-
sium channels by a family of calcium sensors. Nature 2000; 403(6769):
553–556.